Lam Research Corporation vs Macy's Inc — how do they compare? Lam Research Corporation trades at $318.84 (market cap $401.19B), while Macy's Inc trades at $22.67 (market cap $5.95B). The key difference: Lam Research Corporation is far larger — about 67.4× Macy's Inc's market cap, and Macy's Inc pays the higher dividend (3.36%). Which is the better fit depends on your goals — on Pluang, investors hold Lam Research Corporation for 60 Days and Macy's Inc for 58 Days on average.
| LRCX | M | |
|---|---|---|
Market Cap | $401.19B | $5.95B |
Volume | 8,960,892 | 6,030,644 |
Sector | Technology | Consumer Cyclical |
52-Week High | $433.33 | $26.21 |
52-Week Low | $131.37 | $16.51 |
Typical Hold Time | 60 Days | 58 Days |
Enterprise Value | $399.35B | $9.75B |
Dividend Yield | 0.41% | 3.36% |
Signals from Pluang's Aura AI — not financial advice
Lam Research (LRCX) trades at $320.59, down 2.71% on the day, amid a bearish technical signal despite strong fundamentals. The company reported robust earnings beats in recent quarters, with Q2 2026 EPS of $1.82 surpassing the $1.69 estimate, and maintains high profitability with a net income margin of 31.27%. Revenue growth is accelerating, reaching $18.44 billion in 2025, supported by AI-driven demand for semiconductor equipment. Analyst consensus remains strongly bullish with a $375.68 price target, though technical indicators show mixed signals with key support at $314.
LRCX presents a compelling long-term investment opportunity driven by AI infrastructure spending and operational efficiency, but faces near-term volatility from technical bearishness and macroeconomic headwinds. Risks include cyclical semiconductor demand and competitive pressures, yet strong institutional support and consistent earnings outperformance underpin upside potential toward analyst targets.
Macy's (M) trades at $22.79 with strong valuation metrics including a P/E of 8.35 and P/S of 0.27, indicating potential undervaluation. The stock shows bullish technical signals with recent earnings beats in Q2 2026 and raised 2026 guidance. Cash flow improved to $273M in 2025, while revenue stabilized at $23.01B with net income of $582M. The company's 'Bold New Chapter' strategy is driving digital transformation and omnichannel growth.
Investment outlook appears favorable with 31.7% analyst buy ratings and $24.25 consensus price target suggesting 6.4% upside. Key risks include retail sector competition and uneven quarterly performance, but strong dividend yield and turnaround progress support total return potential for patient investors.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Lam Research manufactures equipment used to fabricate semiconductors. The firm is focused on the etching, deposition, and clean markets, which are key steps in the semiconductor manufacturing process, especially for 3D NAND flash storage, advanced DRAM, and leading-edge logic/foundry chipmakers. Lam's flagship Kiyo, Vector, and Sabre products are sold in all major geographies to key customers such as Samsung Electronics, Micron, Intel, and Taiwan Semiconductor Manufacturing.
Read more on LRCX →Founded in 1858 and based in New York City, Macy's operates 570 stores under the Macy's nameplate, 58 stores under the Bloomingdale's nameplate, and 160 freestanding Bluemercury specialty beauty stores (as of the end of fiscal-year 2021). Macy's also operates e-commerce sites and licenses two Bloomingdale's stores in the United Arab Emirates and Kuwait. Women's apparel, accessories, shoes, cosmetics, and fragrances comprised 59% of Macy's 2021 sales.
Read more on M →